Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Neogenomics Inc NEO

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing... see more

Opinion & Analysis (NDAQ:NEO)

No current opinion is available.

Bullboard Posts (NDAQ:NEO)

NeoGenomics, Inc. (NASDAQ:NEO): A Comprehensive Look at the

http://beyondspx.com/2024/07/31/neogenomics-inc-nasdaqneo-a-comprehensive-look-at-the-leading-oncology-diagnostics-provider/
MikeTester - August 2, 2024

Overview

NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology...
snotters - April 6, 2022

RE:spending US$4.5bn to expand capacity at plants in the Chines

China EV startup Nio's shipments are beginning to take off    Nice read!
zeropointenergy - March 19, 2021

spending US$4.5bn to expand capacity at plants in the Chines

Chinese new-vehicle sales on road to recovery in 2021 ... www.eiu.com › Home › The EIU Update   ...
zeropointenergy - March 19, 2021

NGNM - Strong Buy at $1

I like NGNM right here at a $1 per share. They've got a great management team, growing revenues, new cancer tests coming to market...
bpvitale - October 22, 2010

NeoGenomics, Inc. Announces Financial and Ope

NeoGenomics, Inc. Announces Financial and Operating Results for FY 2003; Strong Revenue Gains and Many Accomplishments for the Year ...
631212 - February 25, 2004